Actovegin® reduces PMA-induced inflammation on human cells

PURPOSE: The effect of Actovegin® was investigated on PMA- and LPS-induced human peripheral blood mononuclear cells (PBMCs). METHODS: PBMCs (1 × 10(6) cells/ml) from five blood donors (2 f, 3 m; 45–55 years) were grown in medium and exposed to Actovegin® in the presence or absence of PMA or LPS. Sup...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichl, Franz-Xaver, Högg, Christof, Liu, Fangfang, Schwarz, Markus, Teupser, Daniel, Hickel, Reinhard, Bloch, Wilhelm, Schweikl, Helmut, Thomas, Peter, Summer, Burkhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497287/
https://www.ncbi.nlm.nih.gov/pubmed/32447451
http://dx.doi.org/10.1007/s00421-020-04398-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497287/
https://www.ncbi.nlm.nih.gov/pubmed/32447451
http://dx.doi.org/10.1007/s00421-020-04398-2

Ejemplares similares